Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Breast 3Other 2Thoracic 1Endocrine 1CNS 1

Conditions

Prostatic Neoplasms 2Weight Loss 1Urinary Bladder Neoplasms 1Diabetes Mellitus 1

Interventions

Docetaxel 409pembrolizumab 332Prednisone 290enzalutamide 285Gemcitabine 274Radiotherapy 270Magnetic Resonance Spectroscopy 269Nivolumab 253Abiraterone Acetate 218Cisplatin 212Leuprolide 195Radiosurgery 192Sunitinib 188Carboplatin 161Androgen Antagonists 156bicalutamide 152Specimen Handling 149Goserelin 149Ipilimumab 131Paclitaxel 126acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 122apalutamide 118Cyclophosphamide 117Bevacizumab 116Sorafenib 114Everolimus 111abiraterone 108cabozantinib 105atezolizumab 105Biopsy 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Diet, Carbohydrate-Restricted × Genitourinary × Clear all
NCT03679260 2023-03-30

Carbohydrate Restricted Diet Intervention for Men on Prostate Cancer Active Surveillance

Cedars-Sinai Medical Center

Phase 2 Completed
22 enrolled
Genitourinary

Prostatic Neoplasms, Weight Loss

NCT02716623 2019-07-15

DEAL

University of Kansas Medical Center

Phase NA Completed
5 enrolled
Genitourinary

Urinary Bladder Neoplasms, Diabetes Mellitus

NCT01763944 2018-10-12

CAPS2

Duke University

Phase NA Completed
83 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡